-
-
Russia is among the “top ten” states suffering from the hepatitis C virus. Hepatitis is an inflammation of the liver. The condition can be self-limiting or can progress to fibrosis (scarring), cirrhosis or liver cancer and has five forms: A, B, C, D, E. One of the most dangerous is hepatitis C, nicknamed “a gentle killer” by doctors for its asymptomatic course, up to the chronic form. In it, infected people make up about 5.8 million people, according to this indicator, Russia ranks 6th in the list.
“Affectionate killer,” hepatitis C, which in 98% of cases leads to cirrhosis of the liver and has millions of carriers around the world, is now easy to treat. Due to the newest medicines, the course of treatment will take only a few months. The new method consisted of combining preparations of Sofosbuvir/Ledipasvir (Harvoni). Due to this approach, you can keep hepatitis C virus at bay. The new method is not only safer, but also more effective. The only drawback is the high price.
HEPATITIS C TREATMENT MEDICINES IN INDIA IS 10 TIMES LESS THAN IN RUSSIA
Because of this high cost in Russia, treatment is not available for the vast majority of the population. But the problem of the cost of Sofosbuvir/Ledipasvir for the treatment of hepatitis C has been solved in India. In India the cost of these medicines is 10 times less than in Russia. GILEAD, the leading manufacturer of modern hepatitis C medicines, such as Harvoni, has issued an official license for the production of Sofosbuvir and Ledipasvir and other medicines in India, which significantly reduced the cost of treatment. Sofosbuvir and Ledipasvir manufactured by reputed Indian pharmaceutical company like natco pharma and Mylan under the brand name Hepcinat LP and Myhep LVIR and many more.
With the fall in the cost of new-generation medicines, there could be a possible decline in the percentage of people infected with HCV.
-
You must be logged in to post a comment.